Approval · Notice of Compliance 17222 · 2015
FOSAPREPITANT: Notice of Compliance 17222
Issued August 25, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17222
- Date
- August 25, 2015
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Neurokinin 1 (nk1) receptor antagonist
- Canadian reference product
- EMEND IV (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FOSAPREPITANT | 02436264 | Approved |
Medicinal ingredients
- FOSAPREPITANT DIMEGLUMINE 150 MG per VIAL